株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

シンガポールの開発業務受託機関 (CRO) 市場

Singapore Contract Research Organization Market

発行 Frost & Sullivan 商品コード 337457
出版日 ページ情報 英文 72 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
シンガポールの開発業務受託機関 (CRO) 市場 Singapore Contract Research Organization Market
出版日: 2015年08月12日 ページ情報: 英文 72 Pages
概要

当レポートでは、シンガポールの開発業務受託機関 (CRO) 市場について調査分析し、収益予測 (相別、治療タイプ別) のほか、主な課題、アンメットニーズ、新興動向などについて、体系的な情報を提供しています。

エグゼクティブサマリー

市場概要

  • 製薬市場の概要
  • 市場の見通し

臨床試験市場の概要

  • 臨床試験市場の概要
  • 臨床試験シナリオ
  • 臨床試験のプロファイル
  • CRO市場区分:臨床開発段階別

予測と動向:総合市場

  • 予測の前提条件
  • 評価
  • 収益予測
  • 第I相・第II相セグメント:収益予測
  • 第III相・第IV相セグメント:収益予測
  • 前臨床セグメント:収益予測
  • データ管理セグメント:収益予測
  • 生物統計セグメント:収益予測
  • 中央臨床検査サービスセグメント:収益予測
  • ファーマコビジランス (医薬品安全性管理) セグメント:収益予測
  • 生物学的分析セグメント:収益予測
  • HEORセグメント:収益予測
  • CRO市場:主要動向

規制環境

  • 臨床研究規制概要
  • 臨床研究規制プロセス

競合環境

  • 競合構造
  • 競合分析:主要企業

まとめ

付録

Frost & Sullivanについて

目次
Product Code: 9AB9-00-31-00-00

Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.

This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclinical trials to post-marketing surveillance. It provides detailed information on support services, such as central laboratory services, bio-analytics, and data management. The market insight also analyses Market Engineering measurements, and R&D trends.

Table of Contents

1. SINGAPORE CONTRACT RESEARCH ORGANIZATION MARKET

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Total CRO Market Size by Stages of Clinical Development
  • 4. Market Size Estimation Methodology
  • 5. Scope and Segmentation
  • 6. Key Questions This Study Will Answer
  • 7. Total CRO Market-Market Engineering Measurements
  • 8. CEO's Perspective
  • 9. CEO's Perspective
  • 10. Key Companies to Watch (continued)

Market Overview

  • 1. Pharmaceutical Market Overview
  • 2. Pharmaceutical Market Overview (continued)
  • 3. Market Perspective

Clinical Trials Market Overview

  • 1. Clinical Trials Market Overview
  • 2. Clinical Trials Market Overview (continued)
  • 3. Clinical Trials Scenario
  • 4. Profiles of Clinical Trials
  • 5. Total CRO Market Segmentation by Stages of Clinical Development

Forecasts and Trends-Total CRO Market

  • 1. Forecast Assumptions
  • 2. Measurements
  • 3. Total CRO Market-Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Total CRO Market-Phase I & Phase II
  • 6. Total CRO Market-Phase III & Phase IV
  • 7. Total CRO Market-Preclinical Revenue Forecast
  • 8. Preclinical Revenue Forecast Discussion
  • 9. Total CRO Market-Data Management Revenue Forecast
  • 10. Data Management Revenue Forecast Discussion
  • 11. Total CRO Market-Biostatistics Revenue Forecast
  • 12. Biostatistics Revenue Forecast Discussion
  • 13. Total CRO Market-Central Laboratory Services Revenue Forecast
  • 14. Central Laboratory Services Revenue Forecast Discussion
  • 15. Total CRO Market-Pharmacovigilance Revenue Forecast
  • 16. Pharmacovigilance Revenue Forecast Discussion
  • 17. Total CRO Market-Bioanalytics Revenue Forecast
  • 18. Bioanalytics Revenue Forecast Discussion
  • 19. Total CRO Market-HEOR Revenue Forecast
  • 20. HEOR Revenue Forecast Discussion
  • 21. Total CRO Market-Key Trends

Regulatory Environment

  • 1. Clinical Research Regulatory Overview
  • 2. Clinical Research Regulatory Overview (continued)
  • 3. Clinical Research Regulatory Process

Competitive Environment

  • 1. Competitive Structure
  • 2. Competitive Analysis-Selected Key Market Participants
  • 3. Competitive Analysis-Selected Key Market Participants (continued)
  • 4. Competitive Analysis-Selected Key Market Participants (continued)
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)

The Last Word

  • 1. The Last Word-Discussion
  • 2. Legal Disclaimer

Appendix

  • 1. List of Exhibits
  • 2. List of Exhibits (continued)

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top